| 000 | 01457 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514011729.0 | ||
| 264 | 0 | _c20020214 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a0091-2700 | ||
| 024 | 7 |
_a10.1177/00912700122012607 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKarim, A | |
| 245 | 0 | 0 |
_aA pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cOct 2001 |
||
| 300 |
_a1111-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 |
_aIsoxazoles _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSulfonamides _xadverse effects |
| 700 | 1 | _aLaurent, A | |
| 700 | 1 | _aSlater, M E | |
| 700 | 1 | _aKuss, M E | |
| 700 | 1 | _aQian, J | |
| 700 | 1 | _aCrosby-Sessoms, S L | |
| 700 | 1 | _aHubbard, R C | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 41 _gno. 10 _gp. 1111-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/00912700122012607 _zAvailable from publisher's website |
| 999 |
_c11504052 _d11504052 |
||